Thermo Fisher Scientific Inc. (TMO) is making robust progress with its growth strategy, which bodes well for the upcoming quarters. The spree of innovative product introductions bolsters its portfolio. The company's Bioproduction business is expanding and increasing its capacity to meet the rising demand. Meanwhile, the adverse macroeconomic impacts and currency fluctuations raise concerns for TMO's operations, In the past year, shares of this Zacks Rank #3 (Hold) company have rallied 20.7% compared with th ...